MétaCan
Menu
Back to cohort

Prevention of radiation induced cardiotoxicity in patients with left sided breast cancer: results from a phase 2 clinical trial

2025· article· en· W4412805617 on OpenAlexafffund
D. Ian Paterson, Edith Pituskin, Richard B. Thompson, Kongming Wu, Fang Huang, Karen King, Ericka Wiebe, Susan Chafe, Zsolt Gabos, Keith Tankel, Sunita Ghosh, Aswin Abraham, Govind Menon, Kurian Joseph

Bibliographic record

VenueEuropean Heart Journal Supplements · 2025
Typearticle
Languageen
FieldMedicine
TopicChemotherapy-induced cardiotoxicity and mitigation
Canadian institutionsUniversity of AlbertaCanadian VIGOUR CentreUniversity of Ottawa
FundersAlberta Cancer Foundation
KeywordsMedicineCardiotoxicityBreast cancerInternal medicineOncologyClinical trialRadiation therapyCancerChemotherapySurgery

Abstract

fetched live from OpenAlex

Abstract Background Adjuvant radiotherapy (RT) is an essential component of the optimal management of breast cancer (BC). However, RT-induced risk of cardiac toxicity is a major concern for patients with left sided BC as they are at twice the risk compared to right sided BC. Modern RT-planning techniques that include deep inspiratory breath holding (DIBH) have the potential to mitigate radiation associated cardiotoxicity. Purpose To evaluate the impact of DIBH on cardiac magnetic resonance (CMR) measures of cancer therapy related cardiac dysfunction (CTRCD) in women with left sided breast cancer treated with adjuvant RT in a phase II clinical trial. Methods Eligible patients underwent either free breathing (FB) or DIBH treatment delivery, if the predicted mean heart RT dose was <5 Gy or >5 Gy, respectively. Those eligible for DIBH and FB RT without prior exposure to anthracyclines or trastuzumab (CH) were allocated to cohort I and II respectively, and those receiving DIBH RT with prior exposure to CH were placed in cohort III. Non-contrast CMR scans were acquired at pre-RT and at 16 weeks and 52 weeks post completion of RT to assess left ventricular ejection fraction (LVEF) and LV global longitudinal strain (GLS). CTRCD was defined according to ESC 2022 Cardio-Oncology guidelines with asymptomatic moderate CTRCD defined as a new reduction in LVEF by ≥ 10% to an LVEF of 40-49% and mild CTRCD defined as LVEF ≥ 50% and a new reduction in GLS > 15% from baseline. Change in LV function and CTRCD were compared between groups at 16 and 52 weeks using ANOVA or Chi-square statistics. Results 25 patients received DIBH-RT (cohort 1), 21 received FB-RT (cohort II) and 23 had adjuvant CH prior to DIBH-RT (cohort III). There were significant age differences between cohorts, but baseline LVEF and LV GLS were not significantly different (Table). Mean and maximum heart and LV radiation doses were similar between cohorts (Table). There were no significant changes in LVEF at 16 and 52 weeks and no cases of asymptomatic moderate CTRCD in any of the cohorts. At 16 weeks, mean LV GLS was similar between cohorts but improved from baseline in cohort 1 relative to cohorts 2 and 3, -4.6 ± 15.4% vs. +9.8 ± 8.9 and +4.2 ± 15.4, respectively, p=0.004 (Table, Figure). There were also no cases of mild CTRCD at 16 weeks in cohort 1 compared to 5 in cohort 2 and 6 in cohort 3, p=0.034. The observed group differences in LV GLS and mild CTRCD persisted at 52 weeks. On multivariable regression analysis, baseline LV GLS and maximum heart radiation dose were significant predictors of change in LV GLS at 16 weeks. Conclusions In patients with left-sided breast cancer, mild CTRCD was observed in patients exposed to FB-RT or DIBH-RT plus chemotherapy but not following DIBH-RT alone. Factors predicting change in LV GLS included baseline LV GLS and maximum heart radiation dose.Table Figure

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.139
Threshold uncertainty score0.594

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0020.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.052
GPT teacher head0.392
Teacher spread0.340 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueEuropean Heart Journal SupplementsSame topicChemotherapy-induced cardiotoxicity and mitigationFrench-language works237,207